Main Page  /  Clinical Trials
  
1-609-841-1201          

Clinical Trials

Русский
English

Clinical trials

Completed phase I/IIa clinical trial
Case studies
International Clinical Trials 2019
US clinical trials

Completed phase I/IIa clinical trial



Twenty-seven patients participated in phase I/IIa clinical trials conducted in 4 different clinical centers in Russia.


A high degree of safety was demonstrated in dose escalation studies.
Three groups of five patients each were administered escalating doses of Elenagen™. Only minimal Grade I side effects were observed in some patients.



Elenagen™ was able to reduce and outright cease disease progression
in patients with melanoma, breast, ovary, lung, and renal cancer. Patients admitted into our trial were “salvage patients” who have failed all other available treatment protocols and were in the active disease progression stage. The main goal was to stop the disease progression, which we have achieved.



Restoring tumor sensitivity to chemotherapy.
All patients admitted to the clinical trials already failed multiple previous lines of chemotherapy. However, after treatment with Elenagen™, the patients were able to successfully respond to new rounds of chemotherapy.



Case studies




International Clinical Trials 2019


2019. Phase II clinical trials in Belarus and Brazil.

    • Randomized case-control phase II clinical studies

    • The goal: to test the ability of Elenagen™ to enhance standards of care for

      • Triple negative breast cancer

      • Ovarian cancer

      • Inoperable stomach cancer

      • Pancreatic cancer

    • Observation by the leading US medical centers

    • Pending future international clinical trials in

      • Glioblastoma

      • Metastatic hormone-resistant prostate cancer

      • Metastatic renal cancer

      • Metastatic uterus cancer

      • Melanoma



For any inquiries, please contact:



US clinical trials


  • Anticipated to begin in 2020

  • The goal: to test the ability of Elenagen™ to enhance standards of care for

    • Triple negative breast cancer

    • Ovarian cancer

For any inquiries, please contact:


  
 
Разработка SEO-Online Оптимизация сайта
Работает на Amiro CMS - Free